A Double-blind Trial of Lactobacillus paracasei Strain KW3110 Administration for Immunomodulation in Patients with Pollen Allergy

Background: Lactobacillus paracasei strain KW3110 has been shown by in vitro cytokine secretion analysis to be a potent Th1 inducer and Th2 repressor.Oral administration of L.paracasei strain KW3110 also represses IgE elevation in the ovalbumin sensitized mouse allergy model.Methods: During pollen season from January to April in 2003, a daily dose

read more